Valuation
- Market cap
- —
- Revenue TTM
- $110,748
- Net income TTM
- $-4,648,709
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- —
- Debt to equity
- —
Trading
- Volume
- 145,000
- Avg volume
- 12,570
- Day's range
- $0.15 – $0.48
- Shares out
- —
- Stochastic %K
- 100%
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 heads...
Show more
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.
- Phone
- 832 260 0222
- Website
- https://www.nexalin.com
- Address
- 1776 Yorktown, Suite 550, Houston, United States
Latest news
No headlines yet.
